{"id":153954,"name":"ACELRX PHARMACEUTICALS, INC.","slug":"acelrx-pharmaceuticals-inc","state":"CA","country":"United States of America","description":"Speciality pharmaceutical company","totalSpending":925000,"filings":19,"yearlySpending":[{"year":2018,"income":180000},{"year":2019,"income":195000},{"year":2020,"income":200000},{"year":2021,"income":200000},{"year":2022,"income":150000}],"issues":["HCR","DEF"],"firms":["JEFFREY J. KIMBELL & ASSOCIATES, INC."],"lobbyists":["JEFFREY KIMBELL","JODIE LOCKHART","KEITH STUDDARD","JOHN HERZOG","JOHN RAY","DAVID RUDLOFF","KENNETH HODGE"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Health & Human Services, Dept of (HHS)","Executive Office of the President (EOP)"],"sampleDescriptions":["FDA drug approval process","FDA drug approval process","Issues related to the opioid epidemic and FDA drug approval process","Issues related to the opioid epidemic and FDA drug approval process","FDA drug approval process; Issues related to the opioid epidemic"],"years":[2018,2019,2020,2021,2022]}